VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer

American Journal of Pathology

Volumn 154, Issue 5, 1999, Pages 1381-1390

  Valtola, Reija ^a   Salven, Petri ^b   Heikkilä, Päivi ^a   Taipale, Jussi ^a   Joensuu, Heikki ^b   Rehn, Marko ^c   Pihlajaniemi, Taina ^c   Weich, Herbert ^e   DeWaal, Robert ^d   Alitalo, Kari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; BASEMENT MEMBRANE; BLOOD VESSEL PERMEABILITY; BREAST CANCER; CONTROLLED STUDY; FIBROADENOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL ENDOTHELIUM; METASTASIS; PARACRINE SIGNALING; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; SMOOTH MUSCLE FIBER;

EID: 0032933883     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65392-8     Document Type: Article

References (38)

1. Ferrara N. Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 1997, 18:4-25
2. Shibuya M: Role of VEGF-FLT receptor system in normal and tumor angiogenesis. Adv Cancer Res 1995, 67:281-316
3. Ferrara N: The role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 1999, In press
4. Clauss M, Weich H, Breier G, Knies U, Rockl W, Waltenberger J, Risau W: The vascular endothelial growth factor receptor Flt-1 mediates biological activities: Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 1996, 271:17629-17634
5. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N: Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumour growth in vivo. Nature 1993, 362:841-344
6. Relf M, LeJeune S, Scott P, Fox S, Smith K, Leek R, Moghaddam A, Whitehouse R, Bicknell R, Harris A: Expression of the angiogenic factors vascular endothelial growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 1997, 57:963-969
7. Bicknell R, Lewis C, Ferrara N: Tumour Angiogenesis. Oxford, Oxford University Press, 1997
8. Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, Senger DR, Connolly JL, Schnitt SJ: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 1995, 26:86-91
9. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992, 84:1875-1887
10. Pajusola K, Aprelikova O, Pelicci G, Weich H, Claesson-Welsh L, Alitalo K: Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. Oncogene 1994, 9:3545-3555
11. Sawano A, Takahashi T, Yamaguchi S, Aonuma M, Shibuya M: Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ 1996, 7:213-221
12. Olofsson B, Korpelainen E, Mandriota S, Pepper MS, Aase K, Kumar V, Gunji Y, Jeltsch MM, Shibuya M, Alitalo K, Eriksson U: VEGF-B binds to VEGFR-1, and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci USA 1998, 95:11709-11714
13. Kaipainen A, Korhonen J, MustonenT, van Hinsbergh VM, Fang G-H, Dumont D, Breitman M, Alitalo K: Expression of the fms-like tyrosine kinase FLT4 gene becomes restricted to endothelium of lymphatic vessels during development. Proc Natl Acad Sci USA 1995,92:3566-3570
14. Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K, Breitman M, Alitalo K: Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 1998, 282:946-949
15. Jussila L, Valtola R, Partanen T, Salven P, Helkkilä P, Matikainen M-T, Renkonen R, Kaipainen A, Detmar M, Tschachler E, Alitalo R, Alitalo K: Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res 1998, 58:1599-1604
16. Lymboussaki A, Partanen TA, Olofsson B, Thomas-Crusells J, Fletcher C, deWaal R, Kaipainen A, Alitalo K: Expression of the vascular endothelial growth factor receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am J Pathol 1998, 153:395-403
17. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996, 15:290-298
18. Achen M, Jeltsch M, Kukk E, Mäkinen T, Vital A, Wilks A, Alitalo K, Stacker S: Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4), Proc Natl Acad Sci USA 1998, 95:548-553
19. Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y, Saksela O, Kalkkinen N, Alitalo K: Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 1997, 16:3898-3911
20. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K: Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997, 276:1423-1425
21. Oh S-J, Jeltsch MM, Birkenhager R, McCarthy JE, Weich HA, Christ B, Alitalo K, Wilting J: VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 1997, 188:96-109
22. Witzenbichler B, Asahara T, Murohara T, Silver M, Spyridopoulos I, Magner M, Principe N, Kearney M, Hu J-H, Isner JM: Vascular endothelial growth factor-C (VEGF-C/VEGFR-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol 1998, 153:381-394
23. Cao Y, Linden P, Farnebo J, Cao R, Eriksson A, Kumar V, Qi J-H, Claesson-Welsh L, Alitalo K: Vascular endothelial growth factor induces angiogenesis in vivo. Proc Natl Acad Sci USA 1998, 95: 14389-14394
24. Salven P, Lymboussaki A, Heikkilä P, Joensuu H, Alitalo K: Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol 1998, 153:103-108
25. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27-31
26. Jain R: Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J Natl Cancer Inst 1989, 81:570-576
27. de Waal R, van Altena M, Erhard H: Lack of lymphangiogenesis in human primary cutaneous melanoma: consequences for the mechanism of lymphatic dissemination. Am J Pathol 1997, 150:1951-1957
28. Baish J, Netti P, Jain R: Transmural coupling of fluid flow in microcirculatory network and interstitium in tumors. Microvasc Res 1997, 53:128-41
29. Simon M, Röckl W, Hornig C, Gröne EF, Theis H, Welch HA, Fuchs E, Yayon A, Gröne H-J: Receptors of vescular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: localization and (125I) VEGF binding sites. J Am Soc Nephrol 1998, 9:1032-1044
30. Gasparini G, Harris A: Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 1995, 13:765-782
31. Kerstens H, Poddighe P, Hanselaar A: A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine. J Histochem Cytochem 1995, 43:347-352
32. Saarela J, Ylikärppä R, Rehn M, Purmonen S, Pihlajaniemi T: Complete primary structure of two variant forms of human type XVIII collagen and tissue-specific differences in the expression of the corresponding transcripts. Matrix Biol 1998, 16:319-328
33. Saarela J, Rehn M, Oikarinen A, Autio-Harmainen H, Pihlajaniemi T: The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans. Am J Pathol 1998, 153:611-626.
34. DeVita V, Veronesi U, Pinedo H: Cancer of breast. Cancer Principles & Practice of Oncology, ed 5. 1997, p 1590
35. Barth A, Craig P, Silverstain M: Predictors of axillary node metastases in patients with T1 breast carcinoma. Cancer 1997, 15:1918-1922
36. Leak LV: Electron microscopic observations on lymphatic capillaries and the structural components of the connective tissue-lymph interface. Microvisc Res 1970, 2:361-391
37. O'Morchoe C, O'Morchoe P: Differences in lymphatic and blood capillary permeability: ultrastructural-functional correlations. Lymphology 1987, 20:205-209
38. Dvorak AM, Kohn S, Morgan ES, Fox P, Nagy JA, Dvorak HF: The vesiculo-vacuolar organelle (VVO)-a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. Leuk Biol 1996, 59:100-115